Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDI. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Solve 3-acyl pyrrole synthesis challenges with mild, green copper-catalyzed process. Achieve 60-70% yield, 50-80°C operation, and 99% purity for drug development. Request COA/MSDS now.
Eliminate anhydrous/oxygen-free requirements in 1,2,4-triazole synthesis. Scale to gram-level with biomass-derived glucose. Reduce production costs by 30% for drug development.
Reduce catalyst costs and eliminate inert gas requirements in naphthopyran-2-one synthesis with this 10 mol% Pd-catalyzed method. Achieve 70-90% yields for pharmaceutical intermediates.
Solve polyfluoroarene coupling challenges: 99% selectivity, room-temperature operation, and 85-99% yield. Reduce costs and supply chain risks for API intermediates.
Discover a cost-effective 1,2,4-triazolyl arylamine synthesis method requiring no anhydrous conditions. Ideal for pharma R&D and procurement to reduce production risks and costs.
Discover cost-effective cobalt-catalyzed synthesis of tetrahydro-β-carbolinone for anti-anxiety drugs. High yield, broad functional group tolerance, and scalable to 100 MT/yr. Reduce supply chain risks.
Solve lenvatinib impurity challenges with 98% purity, 80% yield. Our CDMO expertise ensures stable supply for pharma quality control.
Solve supply chain risks with this mild, high-yield palladium-catalyzed route for benzodihydrofuran intermediates. 80%+ yields, broad functional group tolerance, and scalable to 100MT/yr.
Discover a breakthrough synthesis method for chiral fluorine-containing quaternary carbon compounds with >90% enantioselectivity and mild conditions. Reduce supply chain risks for your API development.
Discover a metal-free, high-yield method for chiral 1,3-diamine with >97:3 dr. Reduce costs and supply chain risks in pharmaceutical synthesis.
Solve supply chain risks with 90%+ yield 3-chloro-4-amino maleimide synthesis. Copper-catalyzed, oxygen-tolerant process eliminates expensive anhydrous equipment. Contact for custom manufacturing.
Solve aryl azide synthesis challenges with mild copper-catalyzed routes. 91% yield, no strong acid, and broad substrate scope for stable API production.
Discover a scalable, metal-free synthesis for trifluoromethyl dihydrofuranamine with >99% purity. Reduce supply chain risks and accelerate drug development with our CDMO expertise.
Solve harsh reaction conditions and poor functional group tolerance in trifluoromethyl heterocycle synthesis. Our CDMO expertise ensures scalable, high-purity production for pharma intermediates.
Solve high-temperature synthesis challenges for benzofluorenone compounds. Our CDMO expertise delivers 70-85% yields with mild conditions, reducing production costs by 30%.
Discover a green, high-yield synthesis for 3-acyl pyrrole intermediates. Our CDMO expertise ensures scalable production with >99% purity, reducing your supply chain risks.
Reduce synthesis costs and waste with novel chiral ligands. High-yield, scalable routes for transition metal-catalyzed asymmetric synthesis. Contact for custom production.
Efficient one-pot synthesis of halogenated trifluoromethylpyrrole for optoelectronic materials. Reduce production costs and ensure supply chain stability with our CDMO expertise.
Eliminate explosive peroxides and heavy metals in 1,2,4-triazole synthesis. Our CDMO expertise scales this sulfur-promoted method to 100MT/yr with >99% purity.
Discover how this novel chiral synthesis method achieves >90% optical purity with low-cost reagents, reducing production costs and supply chain risks for pharmaceutical manufacturers.